Farbod Darvishian

Biosketch / Results /

Farbod Darvishian

Associate Professor, Department of Pathology
NYU Pathology Associates

Contact Info

Address
540-562 First Avenue
New York, NY 10016

212/263-0138


BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma
Paoluzzi, Luca; Hanniford, Douglas; Sokolova, Elena; Osman, Iman; Darvishian, Farbod; Wang, Jinhua; Bradner, James E; Hernando, Eva. BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma. Cancer medicine. 2016 May 11;5(6):1183-1193 (2107752)

Immunologic heterogeneity of tumor infiltrating lymphocyte composition in primary melanoma
Weiss, Sarah A; Han, Sung Won; Lui, Kevin; Tchack, Jeremy; Shapiro, Richard; Berman, Russell; Zhong, Judy; Krogsgaard, Michelle; Osman, Iman; Darvishian, Farbod. Immunologic heterogeneity of tumor infiltrating lymphocyte composition in primary melanoma. Human pathology. 2016 Jul 26;:?-? (2191782)

Multifocal Breast Cancer: Distinguishing Independent Tumor Foci From In-Transit Metastases
Alexander, Melissa; Acosta-Gonzalez, Gabriel; Malerba, Stefano; Goldberg, Judith; Darvishian, Farbod. Multifocal Breast Cancer: Distinguishing Independent Tumor Foci From In-Transit Metastases [Meeting Abstract]. Laboratory investigation. 2015 FEB;95:32A-32A (1675592)

Multifocal Breast Cancer: Distinguishing Independent Tumor Foci From In-Transit Metastases
Alexander, Melissa; Acosta-Gonzalez, Gabriel; Malerba, Stefano; Goldberg, Judith; Darvishian, Farbod. Multifocal Breast Cancer: Distinguishing Independent Tumor Foci From In-Transit Metastases [Meeting Abstract]. Modern pathology. 2015 FEB;28:32A-32A (1675632)

Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors
Chang, Gregory A; Tadepalli, Jyothirmayee S; Fleming, Nathaniel H; Lui, Kevin; Shao, Yongzhao; Darvishian, Farbod; Pavlick, Anna; Berman, Russell; Shapiro, Richard; Osman, Iman; Polsky, David. Association between TERT promoter mutations and BRAF/NRAS mutations in patients with primary and metastatic melanoma tumors [Meeting Abstract]. Cancer research. 2015 JUL 15;75:?-? (2029702)